Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency

Martina Huemer, Regina Mulder-Bleile, Patricie Burda, D. Sean Froese, Terttu Suormala, Bruria Ben Zeev, Patrick F. Chinnery, Carlo Dionisi-Vici, Dries Dobbelaere, Gülden Gökcay, Mübeccel Demirkol, Johannes Häberle, Alexander Lossos, Eugen Mengel, Andrew A. Morris, Klary E. Niezen-Koning, Barbara Plecko, Rossella Parini, Dariusz Rokicki, Manuel SchiffMareike Schimmel, Adrian C. Sewell, Wolfgang Sperl, Ute Spiekerkoetter, Beat Steinmann, Grazia Taddeucci, Jose M. Trejo-Gabriel-Galán, Friedrich Trefz, Megumi Tsuji, María Antònia Vilaseca, Jürgen Christoph von Kleist-Retzow, Valerie Walker, Jiri Zeman, Matthias R. Baumgartner, Brian Fowler

Research output: Contribution to journalArticle

Abstract

Background: Severe methylenetetrahydrofolate reductase (MTHFR) deficiency is a rare inborn defect disturbing the remethylation of homocysteine to methionine (1.7–34.8 %) residual enzyme activity had mainly psychiatric symptoms, mental retardation, myelopathy, ataxia and spasticity. Treatment with various combinations of betaine, methionine, folate and cobalamin improved the biochemical and clinical phenotype. During the disease course, patients with very low enzyme activity showed a progression of feeding problems, neurological symptoms, mental retardation, and psychiatric disease while in patients with higher residual enzyme activity, myelopathy, ataxia and spasticity increased. All other symptoms remained stable or improved in both groups upon treatment as did brain imaging in some cases. No clear genotype-phenotype correlation was obvious. Discussion: MTHFR deficiency is a severe disease primarily affecting the central nervous system. Age at presentation and clinical pattern are correlated with residual enzyme activity. Treatment alleviates biochemical abnormalities and clinical symptoms partially.

Original languageEnglish
Pages (from-to)115-124
Number of pages10
JournalJournal of Inherited Metabolic Disease
Volume39
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Huemer, M., Mulder-Bleile, R., Burda, P., Froese, D. S., Suormala, T., Zeev, B. B., Chinnery, P. F., Dionisi-Vici, C., Dobbelaere, D., Gökcay, G., Demirkol, M., Häberle, J., Lossos, A., Mengel, E., Morris, A. A., Niezen-Koning, K. E., Plecko, B., Parini, R., Rokicki, D., ... Fowler, B. (2016). Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency. Journal of Inherited Metabolic Disease, 39(1), 115-124. https://doi.org/10.1007/s10545-015-9860-6